You are currently browsing:

Drug that prevents half of breast cancers carries on working

A drug that halves a woman’s risk of breast cancer continues to work long after they stop taking it, say researchers. The drug, Anastrozole, blocks the production of the hormone oestrogen, which fuels the growth of many breast cancers. It halves the risk of breast cancer during the first five years. Now, however, trials on […]

Read More

Blood test may predict risk of recurrence for breast cancer patients

A special blood test may one day predict if a newly diagnosed breast cancer patient is likely to relapse years later, a City of Hope study suggests. “When patients are first diagnosed with cancer,” says Peter P. Lee, M.D., “it is important to identify those at higher risk for relapse for more aggressive treatments and […]

Read More

New study has found that AI system can detect breast cancer better than clinical experts

We have more news in the race for a cure. A new study has found that an AI system developed by Google Health can identify cancer in breast screening mammograms with fewer false positives, and fewer false negatives than radiologists. To read more about this exciting discovery, click the link: https://www.breakingnews.ie/world/ai-system-can-detect-breast-cancer-better-than-clinical-experts-study-973122.html?fbclid=IwAR1IhGS4aumDvLIQgzuP1ZyFaaoXk-BP1q0Bt9v6le4QINzTqNwBWAN2hfo  

Read More

Researchers identify a process responsible for therapeutic resistance in breast cancer

More positive news! A door to new therapies for overcoming drug resistance may have just opened. Researchers at the Lady Davis Institute have identified a key protein that is required for resistance to chemotherapy in the most aggressive form of breast cancer. To learn more about this exciting news, please click the link below: https://medicalxpress.com/news/2019-12-responsible-therapeutic-resistance-breast-cancer.html?fbclid=IwAR0qGqWRSZDDLAPpebkfXMasFN4rTAah4krYtXjHIG49gMGmjtKVVP9aHCU

Read More

€11.9 Million SFI Research Collaboration Targets Precision Oncology

Minister for Business, Enterprise and Innovation, Heather Humphreys TD, today announced an €11.9m research collaboration in the field of precision oncology, which is supported by the Science Foundation Ireland Strategic Partnership Programme. Precision Oncology Ireland is a consortium of five Irish universities, six Irish cancer research charities and ten companies aiming to develop new diagnostics […]

Read More
X